Alteryx

US02156B1035

AYX

AYX

These are the current Upgrades🟩 for this Monday, the September 18, 2023.

• $AGNC (-1,04 %)
  UBS downgrades from "Neutral" to "Buy", with a Target price of $11.50 (previously $10.50).🟩

• $AIN (+0,96 %)
  TD Cowen Downgrades from "Market Perform" to "Outperform", with a Target price from $106 (previously $100).🟩

• $AYX
  Morgan Stanley downgrades from "Equalweight" to "Overweight", with no change in price target.🟩

• $BCRX (+1,96 %)
  RBC Capital downgrades from "Sector Perform" to "Outperform", with a Target Price from $10 (previously $9).🟩

• $CVNA (+4,77 %)
  Wedbush downgrades from "Underperform" to "Neutral", with a Target Price of $48 (previously $40).🟩

• $DASH (+3,26 %)
  Mizuho Securities downgrades from "Neutral" to "Buy", with a Target price of $105 (previously $90).🟩

• $ESAB (+1,88 %)
  BofA Securities downgrades from "Neutral" to "Buy", with a Target price of $89 (previously $61).🟩

• $IRDM (+1,26 %)
  Deutsche Bank downgrades from "Hold" to "Buy", with no change in price target.🟩

• $JKHY (+0,4 %)
  Northcoast Research downgrades from "Neutral" to "Buy", with a price target of $185.🟩

• $KIM (-1,89 %)
  Mizuho Securities downgrades from "Neutral" to "Buy", with a price target of $20.🟩

• $LHX (-0,1 %)
  Wells Fargo downgrades from "Equal Weight" to "Overweight", with a price target of $209 (previously $204).🟩

• $LMT (-0,72 %)
  Wells Fargo Downgrades from "Underweight" to "Equal Weight", with a Target Price from $440 (previously $433).🟩

• $MU (+1,6 %)
  Deutsche Bank downgrades from "Hold" to "Buy", with a Target price of $85 (previously $65).🟩

• -$NLY (-0,69 %)
  UBS downgrades from "Neutral" to "Buy", with a Target price of $24 (previously $21).🟩

• $ONCT
  H.C. Wainwright downgrades from "Neutral" to "Buy", with a Target price of $2.🟩

• $PB (+1,14 %)
  Hovde Group Downgrades from "Market Perform" to "Outperform".🟩

• $RL (+0,23 %)
  Guggenheim downgrades from "Neutral" to "Buy", with a Target price of $166.🟩

• $SKX (-9,66 %)
  Piper Sandler Downgrades from "Neutral" to "Overweight", with a Target Price of $59 (previously $54).🟩

• $SMPL (-0,02 %)
  Morgan Stanley downgrades from "Equalweight" to "Overweight", with a price target of $40 (previously $37).🟩

• $ZIM (+5,61 %)
  JPMorgan downgrades from "Neutral" to "Overweight", with a price target of $15.40.🟩

Selling pressure used after quarterly figures. Holding period 2 days 🤑

From my point of view, Alteryx is being punished unjustly, which is why I bought it in the hope that the share will not fall any further 😂